immune system
• to the bronchoalveolar lavage of bleomycin-treated mice compared with similarly treated wild-type mice
|
• numbers are significantly decreased in atral follicles
(J:30863)
• numbers were enhanced by treatment with macrophage colony-stimulating factor
(J:30863)
• in the bronchoalveolar lavage of bleomycin-treated mice compared with similarly treated wild-type mice
(J:147697)
|
• decrease in numbers of microglia in the white matter of the brain and spinal cord compared to wild-type mice
|
homeostasis/metabolism
• mice are protected from bleomycin-induced lung fibrosis with fewer recruited alveolar macrophages in the bronchoalveolar lavage compared with similarly treated wild-type mice
|
hematopoietic system
• to the bronchoalveolar lavage of bleomycin-treated mice compared with similarly treated wild-type mice
|
• numbers are significantly decreased in atral follicles
(J:30863)
• numbers were enhanced by treatment with macrophage colony-stimulating factor
(J:30863)
• in the bronchoalveolar lavage of bleomycin-treated mice compared with similarly treated wild-type mice
(J:147697)
|
• decrease in numbers of microglia in the white matter of the brain and spinal cord compared to wild-type mice
|
nervous system
• decrease in numbers of microglia in the white matter of the brain and spinal cord compared to wild-type mice
|
• neurons explanted from embryonic day 17 cortex and cultured for 1 to 2 days have fewer processes and at 4 and 8 days of culture have decreased complexity of neurites compared with controls
|
hearing/vestibular/ear
• latencies are prolonged and amplitudes reduced with an absolute delay in the wave I latency, prolongation of the wave I-V interval, and loss of amlitude and integrity of the later components; subcutaneous administration of CSF1 daily for 10 weeks beginning at 2 days of age ameliorates this phenotype toward normal values
|
vision/eye
• surface visual evoked potentials are dramatically reduced or absent
• intracortical visual evoked potential readings show total intracortical current to be significantly reduced, both in the initial excitation and subsequent inhibition, with deficits found in both transmembrane current flow and multiple unit activity, although the onset latencies of current flow are normal; subcutaneous administration of CSF1 daily for 10 weeks beginning at 2 days of age ameliorates this phenotype toward normal values
• supragranular laminae and thalamorecipient layers both show abnormal processing
• administration of the GABA A antagonist bicuculline results not only in changes in neural firing in the supragranular laminae, as is the case in wild-type controls, but also results in diffusely elevated unit firing in several laminae in homozygotes indicating abnormal intracortical circuitry
|
endocrine/exocrine glands
• the numbers of cells in the atral follicles are significantly reduced but differentiation increases after treatment with macrophage colony-stimulating factor
|
• there are fewer mature follicles in the proestrus ovary compared with controls
|
• fewer antral follicles develop compared with controls
|
reproductive system
• the numbers of cells in the atral follicles are significantly reduced but differentiation increases after treatment with macrophage colony-stimulating factor
|
• there are fewer mature follicles in the proestrus ovary compared with controls
|
• fewer antral follicles develop compared with controls
|
• total number of oocytes ovulated is less than expected
• the number of eggs ovulated at each cycle varies significantly
|
behavior/neurological
N |
• mutants do not exhibit any neurological signs
|
growth/size/body
• growth of mutants is slower than wild-type mice
|
cellular
• the numbers of cells in the atral follicles are significantly reduced but differentiation increases after treatment with macrophage colony-stimulating factor
|
• to the bronchoalveolar lavage of bleomycin-treated mice compared with similarly treated wild-type mice
|